Literature DB >> 27658420

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.

Michel Goedert1, Masami Masuda-Suzukake2, Benjamin Falcon2.   

Abstract

The abnormal aggregation of a small number of known proteins underlies the most common human neurodegenerative diseases. In tauopathies and synucleinopathies, the normally soluble intracellular proteins tau and α-synuclein become insoluble and filamentous. In recent years, non-cell autonomous mechanisms of aggregate formation have come to the fore, suggesting that nucleation-dependent aggregation may occur in a localized fashion in human tauopathies and synucleinopathies, followed by seed-dependent propagation. There is a long prodromal phase between the formation of protein aggregates and the appearance of the first clinical symptoms, which manifest only after extensive propagation, opening novel therapeutic avenues.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Parkinson’s disease; alpha-synuclein; prion-like; tau

Mesh:

Substances:

Year:  2016        PMID: 27658420     DOI: 10.1093/brain/aww230

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  113 in total

Review 1.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

2.  In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.

Authors:  Aurelio J Dregni; Venkata S Mandala; Haifan Wu; Matthew R Elkins; Harrison K Wang; Ivan Hung; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

3.  The cellular prion protein (PrPC) as neuronal receptor for α-synuclein.

Authors:  Laura Urrea; Isidro Ferrer; Rosalina Gavín; José Antonio Del Río
Journal:  Prion       Date:  2017-07-31       Impact factor: 3.931

4.  Is it Useful to Classify PSP and CBD as Different Disorders? Yes.

Authors:  Helen Ling; Antonella Macerollo
Journal:  Mov Disord Clin Pract       Date:  2018-03-06

5.  Physiological C-terminal truncation of α-synuclein potentiates the prion-like formation of pathological inclusions.

Authors:  Zachary A Sorrentino; Niran Vijayaraghavan; Kimberly-Marie Gorion; Cara J Riffe; Kevin H Strang; Jason Caldwell; Benoit I Giasson
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

6.  Comparison of Amyloid β and Tau Spread Models in Alzheimer's Disease.

Authors:  Hang-Rai Kim; Peter Lee; Sang Won Seo; Jee Hoon Roh; Minyoung Oh; Jungsu S Oh; Seung Jun Oh; Jae Seung Kim; Yong Jeong
Journal:  Cereb Cortex       Date:  2019-09-13       Impact factor: 5.357

Review 7.  Is Braak staging valid for all types of Parkinson's disease?

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2018-06-25       Impact factor: 3.575

8.  3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.

Authors:  Jing Zhao; Yanan Zhu; Xuehong Song; Yuanyuan Xiao; Guowei Su; Xinyue Liu; Zhangjie Wang; Yongmei Xu; Jian Liu; David Eliezer; Trudy F Ramlall; Guy Lippens; James Gibson; Fuming Zhang; Robert J Linhardt; Lianchun Wang; Chunyu Wang
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-10       Impact factor: 15.336

Review 9.  Amyloid fibril polymorphism: a challenge for molecular imaging and therapy.

Authors:  M Fändrich; S Nyström; K P R Nilsson; A Böckmann; H LeVine; P Hammarström
Journal:  J Intern Med       Date:  2018-02-19       Impact factor: 8.989

10.  Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation.

Authors:  Shotaro Shimonaka; Shin-Ei Matsumoto; Montasir Elahi; Koichi Ishiguro; Masato Hasegawa; Nobutaka Hattori; Yumiko Motoi
Journal:  J Biol Chem       Date:  2020-08-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.